Susan E. Burwig serves as the Executive Vice President of Operations at Medpace Holdings, Inc., a global clinical research organization (CRO) that provides comprehensive drug development and clinical trial services. With over two decades of experience in the pharmaceutical and biotechnology industries, Burwig has been instrumental in driving operational excellence and strategic growth at Medpace. She joined the company in 2007 and has since played a pivotal role in expanding Medpace's service offerings and enhancing its operational capabilities. Prior to her current role, Burwig held various leadership positions within Medpace, where she demonstrated a keen ability to manage complex clinical trials and foster strong client relationships. Her expertise in project management, process optimization, and team leadership has been crucial in ensuring the successful execution of clinical trials across multiple therapeutic areas. Under her guidance, Medpace has consistently achieved high client satisfaction rates and maintained a reputation for delivering high-quality, timely results. In her capacity as Executive Vice President of Operations, Burwig oversees the day-to-day operations of Medpace's global network of clinical trial sites and laboratories. She is responsible for ensuring that the company's operational strategies align with its overall business objectives, driving continuous improvement initiatives, and maintaining compliance with regulatory standards. Her leadership has been vital in positioning Medpace as a trusted partner for pharmaceutical and biotechnology companies worldwide, contributing significantly to the company's growth and success in the competitive CRO market.